Cargando…
Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: A potential therapeutic application in multiple myeloma
The purpose of these studies was to identify HLA-A2(+) immunogenic peptides derived from XBP1 antigens to induce a multiple myeloma (MM)-specific immune response. Six native peptides from non-spliced XBP1 antigen and three native peptides from spliced XBP1 antigen were selected and evaluated for the...
Autores principales: | Bae, Jooeun, Carrasco, Ruben, Lee, Ann-Hwee, Tai, Yu-Tzu, Anderson, Kenneth C., Munshi, Nikhil C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483794/ https://www.ncbi.nlm.nih.gov/pubmed/21660045 http://dx.doi.org/10.1038/leu.2011.120 |
Ejemplares similares
-
A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T lymphocytes in T cells of Smoldering Myeloma Patients
por: Bae, Jooeun, et al.
Publicado: (2014) -
The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis
por: Carrasco, Daniel R., et al.
Publicado: (2007) -
Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3(+)CD8(+) T cells against Various Solid Tumors
por: Bae, Jooeun, et al.
Publicado: (2015) -
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
por: Bae, Jooeun, et al.
Publicado: (2021) -
Antibody-Based Therapies in Multiple Myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2011)